FXR1 and cancer: It also discusses some of the challenges such as reliable biomarkers, optimal drug delivery systems, drug resistance, and long-term outcomes, as well as some of the opportunities that need to be addressed in order to translate FXR1 research into effective and safe treatments for different cancer patients.